Oral Communications and Posters
Vol. 5 No. s3 (2026): Abstracts of the XXIX National Congress of the Italian Society for the Study of Hemostasis and Thrombosis, 2026

PO138 | THE START-SIAPAV-PAD REGISTRY: RATIONALE, STUDY DESIGN AND BASELINE CHARACTERISTICS OF AN ITALIAN MULTICENTRE REGISTRY

E. Favaretto1, A. Visonà2, C. Amato3, F. Biscetti4|5, B. Zalunardo6, F. Ghirardini7, A. Porfidia8, M. Cini9, E. Antonucci9, W. Ageno10 | 1Angiology Unit, IRCCS azienda ospedaliero-universitaria di Bologna, Italy; 2Osp Riabilitativo di Alta Specializzazione (ORAS), Treviso, Italy; 3Angiology Unit, University of Palermo, Italy; 4Dep of Translational Medicine and Surgery, Catholic University of the Sacred Heart, Roma, Italy; 5UOC of Cardiovascular Internal Medicine, A. Gemelli, Roma, Italy; 6Angiology Unit, Azienda ULSS 2 Marca Trevigiana, Castelfranco Veneto, Treviso, Italy; 7Angiology Unit, Azienda ULSS 1 Dolomiti, Belluno, Italy; 8Dep of Geriatric, Orthopedic, and Rheumatologic Sciences, A. Gemelli IRCCS University Hospital Foundation, Roma, Italy; 9Fondazione Arianna Anticoagulazione, Bologna, Italy; 10Dep of Medicine, University of Padua, Italy

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 26 October 2026
58
Views
32
Downloads

Authors

Background. Peripheral artery disease (PAD) is a common and clinically heterogeneous manifestation of systemic atherosclerosis, PAD reflects systemic atherosclerotic burden and confers high cardiovascular morbidity and mortality rates. In Italy, contemporary real-world evidence on diagnostic pathways, adherence to GDMT, use of revascularisation strategies, and on long-term outcomes remains fragmented. Heterogeneous patient pathways, involvement of multiple specialties, and limited number of high-volume centres reduce the feasibility of adequately powered randomised clinical trials across the full clinical disease spectrum. Thus, prospective observational research is essential to generate high-quality, generalisable evidence to guide everyday practice. The START-SIAPAV-PAD registry was designed to describe characteristics, management and clinical history of patients with PAD in Italy. Baseline characteristics and treatment are here reported
Methods. START-SIAPAV-PAD is a prospective, multicentre, observational registry enrolling consecutive adults with objectively documented symptomatic PAD managed at 20 Italian Vascular centres. Standardised electronic case-report forms collect demographics, risk factors, comorbidities, haemodynamic parameters, vascular anatomy, medical therapies. Follow-up is planned for a minimum of 3 years. PAD severity is classified according to the Leriche–Fontaine scale, and risk-factor targets follow the 2024 ESC guidelines
Results. The present analysis includes 517 patients (72.0% male; median age 71 years) with a high prevalence of hypertension (79.2%), dyslipidaemia (85.0%), diabetes (36.9%), smoking (96.1% current or former) and chronic kidney disease (21.2%). Nearly half reported a walking distance <200 m, 77.5% had a resting ankle–brachial index ≤0.80, and 17.2% presented with Leriche–Fontaine stage IV. Femoropopliteal disease was most frequent (69.8%), with multilevel involvement in 43.4%. Previous revascularisation was common, major amputation was rare. LDL-cholesterol targets (<55 mg/dL) were achieved in 27.9% despite lipid-lowering therapy in 82.1%. Dual pathway inhibition, advanced lipid-lowering therapies, supervised exercise and structured smoking-cessation programmes were insufficiently adopted.
Conclusions. In a population with advanced PAD and multiple risk factors we observed a substantial gap between guideline recommendations and real-world practice. Longitudinal follow-up will assess outcomes and opportunities to improve PAD management

Downloads

Download data is not yet available.

Citations

How to Cite



1.
Favaretto E. PO138 | THE START-SIAPAV-PAD REGISTRY: RATIONALE, STUDY DESIGN AND BASELINE CHARACTERISTICS OF AN ITALIAN MULTICENTRE REGISTRY: E. Favaretto1, A. Visonà2, C. Amato3, F. Biscetti4|5, B. Zalunardo6, F. Ghirardini7, A. Porfidia8, M. Cini9, E. Antonucci9, W. Ageno10 | 1Angiology Unit, IRCCS azienda ospedaliero-universitaria di Bologna, Italy; 2Osp Riabilitativo di Alta Specializzazione (ORAS), Treviso, Italy; 3Angiology Unit, University of Palermo, Italy; 4Dep of Translational Medicine and Surgery, Catholic University of the Sacred Heart, Roma, Italy; 5UOC of Cardiovascular Internal Medicine, A. Gemelli, Roma, Italy; 6Angiology Unit, Azienda ULSS 2 Marca Trevigiana, Castelfranco Veneto, Treviso, Italy; 7Angiology Unit, Azienda ULSS 1 Dolomiti, Belluno, Italy; 8Dep of Geriatric, Orthopedic, and Rheumatologic Sciences, A. Gemelli IRCCS University Hospital Foundation, Roma, Italy; 9Fondazione Arianna Anticoagulazione, Bologna, Italy; 10Dep of Medicine, University of Padua, Italy. Bleeding Thromb Vasc Biol [Internet]. 2026 Oct. 26 [cited 2026 Nov. 20];5(s3). Available from: https://www.btvb.org/btvb/article/view/954